Adjuvant chemotherapy for completely rsected non-small cell lung cancer with TS-1 - evaluation of predictive factors for prognosis
Phase 2
- Conditions
- completely resected non-small cell lung cancer
- Registration Number
- JPRN-UMIN000001049
- Lead Sponsor
- Division of General Thoracic Surgery, Keio University, School of Medicine,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1) with interstitial change or fobrotic change on chest X ray film or chest CT scan 2) massive pleural effusion or ascites 3) with active double cancer 4) with intractable angina pectoris, myocardial infarction, cardiac failure, intractable diabetes mellitus, hypertension, sever infection, ileus, SVC syndrome, abnormal coagulability 5) watery diarrhea 6) pregnant, nursing woman or woman who is likely to be pregnant 7) men with partner willing to get pregnant 8) with severe drug allergy 9) with hypersensitivity to elements of TS-1 10) under medication with 5-FU 11) under medication with Flucytocine 12) doctor's decision not to be registered to this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To identify the predictive factors for TS-1 sensitivity as adjuvant chemotherapy
- Secondary Outcome Measures
Name Time Method Feasibility and safety